Q3 2023
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0000950170-23-062079
Q3 2023 · 10-Q
Revenue$1.00M$1.00M no prior Q3 2022 on fileno prior Q4 2022 on file
Net Income-$723.11K-$723.11K no prior Q3 2022 on fileN/M vs Q4 2022
EPS Diluted-$0.01-$0.01 no prior Q3 2022 on fileN/M vs Q4 2022
Operating Income-$1,146,888—
Operating Cash Flowderived-$1,371,549—
Free Cash Flowderived-$1,374,293—
Margins · derived
Operating margin-114.7%
Net margin-72.3%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2023 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $1.00M | — | — | — |
| Net Income | -$723.11K | -$3.70M | -$2.38M | -$6.78M |
| EPS Diluted | -$0.01 | -$0.08 | -$0.05 | -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR